Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 12/4/2012 10:16:24 AM : Outperform Start Price: $1.72 LXRX Score: +7.72

excellent price entry point with a couple of positive news items looming

Featured Broker Partners


Advertisement